Funded Projects Our Sponsors
1. DST SERB-YS 2015-2018 27.65 Lakhs
"Discovery of novel organoruthenium based phototoxic cancer cell markers: A detection and termination approach for A3 receptor targeted Photodynamic Therapy"
​
2. DST-EMR (CO-PI) 2017-2020 29.5 lakhs
​
“Synthesis and characterization of novel 2-arylbenzothiazole/benzoxazole, quinoxaline and phenanthroline analogues as fluorescent probes and cancer theranostics applications"
​
3. DST-SERB CRG 2021-2024 42 lakhs
​
Emergence of mitochondria targeting Ir(III)/Re(I)based multinuclear complexes as cancer photo-theranostic agent
​
​
4. CSIR-EMR 2023-2026 28 lakhs
​
Design of Heterobinuclear Ruthenium (II) – Vanadium (IV) Complexes as Chemical Nucleases
